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RESEARCH ARTICLE Open Access
Ingestion of 10 grams of whey protein prior to a
single bout of resistance exercise does not
augment Akt/mTOR pathway signaling compared
to carbohydrate
Matthew B Cooke1,3, Paul La Bounty1, Thomas Buford1,4, Brian Shelmadine1, Liz Redd1, Geoffrey Hudson1,5 and
Darryn S Willoughby1,2*
Abstract
Background: This study examined the effects of a whey protein supplement in conjunction with an acute bout of
lower body resistance exercise, in recreationally-active males, on serum insulin and insulin like growth factor 1 (IGF-1)
and Akt/mTOR signaling markers indicative of muscle protein synthesis: insulin receptor substrate 1 (IRS-1), AKT,
mammalian target of rapamycin (mTOR), p70S6 kinase (p70S6K) and 4E-binding protein 1 (4E-BP1).
Methods: In a randomized, double-blind, cross-over design, 10 males ingested 1 week apart, either 10 g of whey
protein (5.25 g EAAs) or carbohydrate (maltodextrose), 30 min prior to a lower-body resistance exercise bout. The
resistance exercise bout consisted of 4 sets of 8-10 reps at 80% of the one repetition maximum (RM) on the angled leg
press and knee extension exercises. Blood and muscle samples were obtained prior to, and 30 min following supplement
ingestion and 15 min and 120 min post-exercise. Serum and muscle data were analyzed using two-way ANOVA.
Results: No significant differences were observed for IGF-1 (p > 0.05). A significant main effect for Test was
observed for serum insulin (p < 0.01) at 30 min post-ingestion and 15 and 120 min post-exercise, with no
Supplement × Test interaction (p > 0.05). For the Akt/MTOR signaling intermediates, no significant Supplement ×
Test interactions were observed (p > 0.05). However, significant main effects for Test were observed for
phosphorylated concentrations of IRS, mTOR, and p70S6K, as all were elevated at 15 min post-exercise (p < 0.05).
Additionally, a significant main effect for Test was noted for 4E-BP1 (p < 0.05), as it was decreased at 15 min post-
exercise.
Conclusion: Ingestion of 10 g of whey protein prior to an acute bout of lower body resistance exercise had no
significant preferential effect compared to carbohydrate on systemic and cellular signaling markers indicative of
muscle protein synthesis in untrained individuals.
Introduction
The maintenance of skeletal muscle mass is determined by
the long-term net balance of skeletal muscle protein
synthesis (MPS) and muscle protein breakdown, defined
by net protein balance. Though the balance between MPS
and muscle protein breakdown is dependent upon feeding
state [1-6] as well as training status [7,8], changes in net
protein balance are thought to occur predominantly
through changes in MPS, which is responsive to both
resistance exercise and amino acid provision [9,10]. Resis-
tance exercise leads to acute up-regulation of the inward
amino acid transport [11] to the muscle resulting in an
elevated fractional synthetic rate of muscle protein for as
many as 48 hours following each exercise bout [12].
Some of the principle intracellular signaling pathways
involved in MPS are becoming more defined in the litera-
ture [13]. As a result, determining the activity of the var-
ious pathways, specifically their intermediates, are often
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used as markers of MPS. MPS is stimulated, at least in
part, by the Akt/mTOR pathway, in which pathway inter-
mediate activity is affected by the level of phosphorylation
at different amino acid sites [14]. Specifically, the regula-
tion of translation initiation via the Akt/mTOR pathway is
recognized as a significant regulator of MPS [15]. Key
downstream targets of the kinase mTOR include the
eukaryotic initiation factor 4E (eIF4E) binding protein (4E-
BP1), which upon phosphorylation releases its inhibition
over eIF4E to promote 5’-methylguanosine cap-dependent
translation initiation and p70S6 kinase (p70S6K) [16].
Phosphorylation of 4E-BP1 is important due to the fact
that it prevents the interaction and inhibition of 4E-BP1
with eIF4E and hence, increases translation and MPS [16].
Conversely, p70S6K influences MPS partially through
ribosomal protein S6 (rpS6) as well as through some other
proteins such as eukaryotic elongation factor 2 (eEF2) [17].
Ingestion of supplementary protein (whole or as indivi-
dual amino acids), either before or immediately following
resistance exercise training, enhances Akt/mTOR pathway
activity and MPS [13,14]. Notwithstanding, ingestion of
protein or essential amino acids (EAA) with or without
carbohydrate prior to, during, and in the early recovery
phase following a bout of resistance exercise can lead to
increased phosphorylation of mTOR [15,18], p70S6K
[19-21], and rpS6 [22,23] within the first 4 hr post-exercise
in both rodent and human models. These results also sug-
gest that timing of ingestion is important, with increased
circulation and nutrient transport to the skeletal muscle
following exercise occurring concomitantly within the
time period when MPS has the greatest elevation in
response to exercise [12,24,25]. In addition, protein source
and/or dosage appear to play a key role in pre- and post-
exercise muscle protein kinetics [26,27]. As little as 10 g of
protein (4.2 g EAA) has been shown to stimulate MPS fol-
lowing resistance exercise [27], while acute ingestion of
between 20-40 g of intact protein [28], or 9-10 g of EAA
[25], seems to induce a plateau in MPS independent of
exercise.
Albumin protein intake at a dose of 10 g (4.3 g EAAs)
has been shown to significantly increase MPS, but had no
effect on the activities of the Akt/mTOR pathway inter-
mediates S6K1 (Thr389), rps6 (Ser240/244), or eIF2Bε
(Ser539) after resistance exercise [10]. As a result, we
sought to determine if 10 g of whey protein, but with 5.25
g of EAAs, would produce increases in other key Akt/
mTOR signalling intermediates following resistance exer-
cise. Therefore, the primary purpose of this study was to
determine the consumption of a whey protein supplement
prior to an acute bout of lower body resistance exercise in
recreationally active males on serum insulin and IGF-1
and the Akt/mTOR signaling markers indicative of MPS:
IRS-1, AKT, mTOR, p70S6K and 4E-BP1.
Methods
Participants
Ten apparently healthy, recreationally-active (exercise 2-
3 times per week), but not resistance-trained (no regular
resistance training for at least one year) male participants
(20.1 ± 1.4 yrs, 174 ± 8.7 cm, 78.5 ± 12 kg,) participated
in this study. All subjects signed informed consent docu-
ments and the study was approved by the Baylor Univer-
sity Institutional Review Board for the Protection of
Human Subjects prior to any data collection. Subjects
were not allowed to participate in this study if they
reported any of the following: 1) current or past history
of anabolic steroid use; 2) any metabolic disorders or tak-
ing any thyroid, hyperlipidmeic, hypoglycemic, anti-
hypertensive, or androgenic medications; 3) ingested any
ergogenic levels of creatine, HMB, thermogenics, ribose,
pro-hormones (i.e., DHEA, androstendione, etc.) or other
purported anabolic or ergogenic nutritional supplements
within 2 months prior to beginning the study; 4) not tak-
ing any additional nutritional supplement or contraindi-
cated prescription medication during the protocol.
Experimental design
The study was conducted in a cross-over, randomized,
double-blinded, and placebo-controlled manner. Partici-
pants expressing interest in the study were interviewed on
the phone/or via email to determine whether they appear
to qualify to participate in this study. Participants believed
to meet eligibility criteria were then invited to attend an
entry/familiarization session. Once reporting to the lab,
participants completed a medical history questionnaire
and underwent a general physical examination to deter-
mine whether they met eligibility criteria. Once cleared,
participants were familiarized to the study protocol via a
verbal and written explanation outlining the study design.
All eligible participants who agreed to participate in the
study read and signed the university-approved informed
consent documents. Participants were familiarized with
the angled leg press and leg extension machines, the cor-
rect technique in performing each of the exercises, and
then performed two low-resistance (30% of body mass)
practice/warm-up sets of 10 repetitions on each exercise
to familiarize them with the protocol and to also insure
that they were able to complete the protocol before being
formally admitted to the study. Participants then com-
pleted an initial strength test to assess their one repetition
maximum (1-RM) for each leg on the angled leg press
(Nebula Fitness, Inc., Versailles, OH), and leg extension
(Body Masters, Inc., Rayne, LA) exercises using standard
guidelines routinely employed our laboratory [29]. Follow-
ing the practice trials, participants were scheduled to
return 48 hours later for testing. Participants were asked
to not change their dietary habits in any way throughout
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the study. This was monitored by having each participant
document dietary intake for two days before each testing
session. In addition, each participant was instructed to fast
for eight hours and not to perform any physical activity
for the 48 hours proceeding each testing session.
Resistance exercise protocol
At the beginning of each testing session, participants
had their body mass measured according to standard
procedures using a self-calibrating digital scale (Health-
O-Meter, Bridgeview, IL, USA) with an accuracy of ±
0.02 kg. Participants performed two separate bouts of
resistance exercise, each session involving only one leg,
each separated by two weeks. The supplement and leg
utilized for the first exercise bout was randomly
assigned. Using only one leg, participants performed 4
sets of 8-10 repetitions at 75%-80% 1-RM on the angled
leg press (Nebula Fitness, Inc., Versailles, OH) and knee
extension (Body Masters, Inc., Rayne, LA) exercises.
Each set was performed over the course of 25-30 sec-
onds and followed by 120 seconds of rest, while 150 sec-
onds of rest (1:5, work: rest ratio) were allowed between
the two exercises. Training volume for each exercise
was calculated by multiplying total number of reps by
the total amount of weight lifted over the four sets.
Supplementation protocol
Participants were assigned in a double-blind and rando-
mized manner to orally ingest 10 grams of maltodextrose
placebo (CHO) or whey protein (WP) containing 5.25 g of
EAAs, mixed with 500 ml of water. Supplements were
ingested 30 minutes before each exercise session. Both
supplements were isocaloric and independently prepared
in individually blinded packages (Glanbia Nutritionals,
Twin Falls, ID, USA). The amino acid composition of the
WP supplement is displayed in Table 1.
Dietary inventories
For two days immediately prior to each testing session,
participants were instructed to record all food and fluid
intake, which was reflective of their normal dietary intake.
Dietary inventories were then analyzed for average energy
and macronutrient intake using the ESHA Food Processor
Nutritional Analysis software (Salem, OR, USA).
Blood and muscle collection procedures
Approximately 20 ml of venous blood was obtained from
an antecubital vein using standard phlebotomy procedures
on four separate occasions at each of the two resistance
exercise sessions; 1) 30 min prior to exercise and ingestion
of the supplement, 2) immediately before exercise follow-
ing ingestion of the supplement, 3) 15 min post-exercise,
and 4) 120 min post-exercise. Blood analyzed for serum
IGF and insulin were placed into two serum separation
tubes and immediately centrifuged at 1,100 g for 15 min.
Serum was separated and stored at -80°C in polypropylene
cryovials for later analysis.
Approximately 50-75 mg of muscle was obtained from
the lateral portion of the vastus lateralis midway between
the patella and iliac crest of the leg using a 5-mm Berg-
strom style biopsy needle. Muscle samples were taken on
3 separate occasions at each of the two resistance exercise
sessions; 1) 30 min prior to exercise and ingestion of the
supplement, 2) 15 min post-exercise, and 3) 120 min post-
exercise. Participants were instructed to refrain from exer-
cise 48 hr prior to each muscle biopsy. After removal, adi-
pose tissue was trimmed from the muscle specimens and
immediately frozen in liquid nitrogen and then stored at
-80°C for later analysis.
Serum IGF and insulin
The concentrations of serum insulin and IGF-1 were
determined in duplicate and the average concentrations
reported using commercially available enzyme-linked
immunoabsorbent assay (ELISA) kits (Diagnostic Systems
Laboratories, Webster, TX; Biosource, Camarillo, CA).
Standard curves were generated using specific control pep-
tides. Concentrations were determined at an optical den-
sity of 450 nm with a microplate reader (Wallac Victor
Table 1 Amino acid composition of the whey protein
(WP) supplement (g/500 ml)
Essential Amino Acids (EAAs) Concentration (g)
Isoleucine 0.61
Leucine 1.55
Lysine 0.76
Threonine 0.85
Valine 0.63
Methionine 0.32
Tryptophan 0.18
Phenylalanine 0.35
Total EAAs 5.25
Non-Essential Amino Acids (NEAAs) Concentration (g)
Aspartic Acid 0.94
Serine 0.45
Glutamic Acid 1.47
Glycine 0.14
Alanine 0.59
Tyrosine 0.27
Histidine 0.16
Arginine 0.14
Proline 0.44
Cystine 0.15
Total NEAAs 4.75
Total Amino Acids 10.00
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1420, Perkin Elmer, Boston, MA, USA). The overall intra-
assay percent coefficient of variation was 4.6% and 2.9%
for insulin and IGF-1, respectively.
IRS-1 and Akt/mTOR signaling pathway protein
expression
Approximately 20 mg of each muscle sample was homo-
genized using a commercial cell extraction buffer (Bio-
source, Camarillo, CA, USA) and a tissue homogenizer.
The cell extraction buffer was supplemented with 1 mM
phenylmethanesulphonylfluoride (PMSF) and a protease
inhibitor cocktail (Sigma Chemical Company, St. Louis,
MO, USA) with broad specificity for the inhibition of ser-
ine, cysteine, and metallo-proteases. Muscle homogenates
were analyzed for phosphorylated IRS-1 (Ser312), Akt
(Ser473), 4E-BP1 (Thr46) and p70S6K (Thr389) using
commercially-available phosphoELISA kits (Invitrogen,
Carlsbad, CA, USA). This sensitivity of these particular
assays is reported by the manufacturer to be less than
1 U/mL. The absorbances, which are directly proportional
to the concentration in the samples, were determined at
450 nm with a microplate reader (Wallac Victor 1420,
Perkin Elmer, Boston MA, USA). A set of standards of
known concentrations for each phosphorylated muscle
variable were utilized to construct standard curves by plot-
ting the net absorbance values of the standards against
their respective protein concentrations. By applying a four
part parameter curve using MikroWin microplate data
reduction software (Microtek Lab Systems, Germany), the
concentrations in the muscle samples were appropriately
calculated. Protein concentrations were expressed relative
to muscle wet-weight. The overall intra-assay percent
coefficient of variation for all assays was less than 7%
Phosphorylated mTOR was assessed through the use
of ELISA used by methods previously described [29]. A
polyclonal antibody specific for phosphorylated mTOR
(Ser 2448), where target antigen specificities have been
verified through Western blotting by the manufacturer,
was purchased from Santa Cruz Biotech (Santa Cruz,
CA). Initially, the antibody was diluted to 0.5 μg/ml in
coating buffer (Na2CO3, NaHCO3, and ddH2O, pH 9.6)
and allowed to incubate at room temperature overnight.
Following incubation, the plates were washed (1 × phos-
phate buffered saline, Tween-20), blocked (10 × phos-
phate buffered saline, bovine serum albumin, ddH2O),
washed, and then incubated with a secondary antibody
(IgG conjugated to HRP) diluted to 0.5 μg/ml in dilution
buffer (10 × phosphate buffered saline, Tween-20,
bovine serum albumin, ddH2O). After washing, a stabi-
lized TMB chromogen was added and the plates were
covered and placed in the dark for the last 30-min prior
to being stopped with 0.2 M sulphuric acid. The subse-
quent absorbances, which are directly proportional to
the concentration of the phosphorlyated mTOR in the
samples, were measured at a wavelength of 450 nm.
There were no standards used in this ELISA, thus no
standard curve was created. Therefore, the absorbances
relative to muscle weight were assessed. The overall
intra-assay percent coefficient of variation was 7.12%.
Statistical analyses
Data are presented in all tables and throughout the text as
mean ± SD. Serum IGF and insulin were analyzed using
2 × 4 [Supplement (CHO, WP) × Test (pre, 30 min post
supp, 15 min post-ex, and 120 min post-ex)] factorial ana-
lyses of variance (ANOVA) with repeated measures on the
Test factor. Muscle protein levels were analyzed using 2 ×
3 [Supplement (CHO, WP) × Test (pre, 15 min post-ex,
and 120 min post-ex)] factorial ANOVA with repeated
measures on the Test factor. Further analysis of the main
effects was performed by separate one-way ANOVAs. Sig-
nificant between-group differences were determined using
Bonferroni Post-Hoc Test. Participant characteristics,
resistance exercise volume, and 1-RMs for the angled leg
press and leg extension exercises for each testing session
were analyzed using a paired sample t-test. All statistical
procedures were performed using SPSS 16.0 software and
a probability level of p < 0.05 was adopted throughout.
Results
Participant characteristics and supplement side effects
There were no significant differences in the body weight,
resting blood pressure, or heart rate between the two test-
ing sessions (data not shown). In a post-study question-
naire administered in a blinded manner, no adverse events
were reported concerning the supplementation or study
protocol.
Dietary analysis
Analysis of dietary intake (excluding supplementation)
for two days immediately prior to each testing session
revealed no differences (p > 0.05) in total caloric, pro-
tein, fat, or carbohydrate intake between testing session
during the course of the study (Table 2).
Muscle strength and resistance exercise volume
There were no significant differences in the 1-RM values
between legs at each testing session for the angled leg
press (p = 0.35) and leg extension (p = 0.42) exercises.
The 1-RM for the leg press was 156.05 ± 18.86 kg for the
right leg and 154.29 ± 25.52 kg for the left leg, and the 1-
RM for the leg extension was 44.94 ± 3.91 kg for the
right leg and 44.69 ± 5.11 kg for the left leg. Additionally,
there were no significant differences in the resistance
exercise volume between the two testing sessions. The
volume for leg press was 4744.5 ± 960.4 kg for WP and
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4841.6 ± 1212.9 kg for CHO (p = 0.89), and the volume
for leg extension was 1187.5 ± 267.6 kg for WP and
1285.2 ± 180.1 kg for CHO (p = 0.35).
Serum IGF-1 and insulin
For IGF-1, no significant main effects for Supplement
and Test or the Supplement × Test interaction were
observed (p > 0.05) (Table 3). For insulin, no significant
main effect for Supplement or the Supplement × Test
interaction was observed (p > 0.05); although, a signifi-
cant main effect for Test (p < 0.001) was observed. Post-
hoc analysis showed significant differences between base-
line, 30 min post-supplement ingestion, 15 min post-
exercise, and 120 min post-exercise (Table 3).
Akt/mTOR signaling intermediates
While no significant main effects for Supplement or the
Supplement × Test interaction were observed for any of
the variables (p > 0.05), a significant main effect for Test
(p < 0.05) was observed for IRS-1 (p = 0.040), mTOR
(p = 0.002), p70S6K (p = 0.046), and 4E-BP1 (p = 0.001).
No significant main effects for Test was observed for Akt
(p = 0.359). Subsequent analyses revealed a significant
increase from baseline in IRS-1 at 15 and 120 m post-
exercise, an increase in mTOR and p70S6K at 15 min
post-exercise, and a significant decrease in 4E-BP1 at 15
min post-exercise (Table 4).
Discussion
In the present study, we chose to assess changes in the
activity of Akt/mTOR pathway intermediates as markers
of MPS in response to resistance exercise after ingesting
10 g of whey protein. As a result, we observed resistance
exercise to effectively activate signaling intermediates of
the Akt/mTOR pathway. Specifically, we demonstrated
increased phosphorylation of IRS-1, AKT, and mTOR.
Relative to their downstream targets, p70S6K was hyper-
phosphorylated at 15 min post-exercise, whereas 4E-BP1
was hypo-phosphorylated at 15 min post-exercise. Conver-
sely, we also observed that ingesting 10 g of whey protein
was unable to induce a greater response in such kinase
phosphorylation when compared to ingesting carbohy-
drate. Therefore, our results suggest that ingestion of 10 g
of whey protein (5.25 g EAAs) is no different than an
equal amount of carbohydrate at enhancing the activity of
systemic and cellular signaling markers indicative of MPS
following resistance exercise.
Resistance exercise and amino acids effectively stimu-
late MPS [30]. Based on previous studies, the role that
nutrient ingestion plays in activating the Akt/mTOR
pathway [15,18-20] is not completely understood, and
may likely be related to the amount of amino acids avail-
able or whether co-ingested with carbohydrate. Previous
studies have demonstrated that 20 g of whey protein (8.6
g EAAs) [10] and 10 g EAAs [26] maximally stimulated
MPS, but that MPS was also increased even at whey pro-
tein doses of 5 g (2.2 g EAAs) and 10 g (4.3 g EAAs) [10]
and an EAA dose of 5 g [26]. When smaller amounts of
EAAs (3-6 g) were ingested, with [31] and without [32]
carbohydrate, the post-exercise increase in MPS was
similar, but greater than basal or post-exercise fasted
levels. In the present study, rather than assessing MPS,
our interest was primarily focused on the extent with
which 10 g of whey protein comprised of 5.25 EAAs
would affect the activity of the Akt/mTOR pathway after
resistance exercise when compared to carbohydrate alone
Table 2 Dietary analyses performed two days
immediately prior to each testing session
Dietary Variable WP CHO p-value
Total Calories (kcal/kg/day) 31.14 ± 7.3 30.43 ± 5.1 0.84
Protein (g/kg/day) 0.83 ± 0.2 0.86 ± 0.1 0.73
Fat (g/kg/day) 0.93 ± 0.1 0.96 ± 0.1 0.22
Carbohydrate (g/kg/day) 4.40 ± 0.9 4.22 ± 1.32 0.13
Data are means ± standard deviations. SI unit conversion factor: 1 kcal = 4.2
kJ. Values exclude supplementation dose.
Table 3 Serum IGF-1 and insulin levels for WP and CHO
Variable Time Point WP CHO p-value
IGF-1 (ng/ml) Baseline 0.46 ± 0.4 0.39 ± 0.3 Supplement (S) = 0.64
30 min post-ingestion 0.47 ± 0.4 0.45 ± 0.4 Test (T) = 0.34
15 min post-exercise 0.44 ± 0.5 0.39 ± 0.3 S × T = 0.89
120 min post-exercise 0.50 ± 0.4 0.44 ± 0.3
Insulin (μIU/ml) Baseline 12.83 ± 6.1 14.05 ± 7.1 Supplement (S) = 0.95
30 min post-ingestion 51.90 ± 25.3 50.59 ± 34.9 Test (T) = 0.001†¥#
15 min post-exercise 23.60 ± 14.1 14.62 ± 8.9 S × T = 0.76
120 min post-exercise 10.08 ± 6.5 9.33 ± 5.5
Data are means ± standard deviations.
† represents significant difference from baseline at 30 min post-ingestion.
¥ represents significant difference from baseline at 15 min post-exercise.
# represents significant difference from baseline at 120 min post-exercise.
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and if this activity might also be systemically affected by
either insulin or IGF-1. The reason for our interest was
an attempt to discern if the 5.25 g of EAAs contained
within 10 g of whey protein, without carbohydrate, was
adequate to activate the Akt/mTOR compared to carbo-
hydrate in response to a single bout of resistance exer-
cise. Our interest was heightened by a previous study in
which albumin protein intake at 10 g (4.3 g EAAs) signif-
icantly increased MPS, and maximally when 20 g (8.6 g
EAAs) and 40 g (16.4 g EAAs) were ingested, yet none of
the three concentrations had any affect on the activities
of the Akt/mTOR pathway intermediates S6K1 (Thr389),
rps6 (Ser240/244), or eIF2Bε (Ser539) at 60 and 240 min
post-exercise [10]. Despite previous evidence indicating
otherwise [10], we were curious to determine if 10 g of
whey protein would produce increases in other key Akt/
mTOR signalling intermediates following resistance
exercise.
It is evident that acute resistance exercise results in a
significant increase in the rate of initiation of protein
synthesis compared with resting muscle [33]. It is sug-
gested that signal transduction pathways control the rate
of initiation of MPS, and appear to be the key factors in
the hypertrophic process [34,35]. Of particular impor-
tance is the complex myriad of signaling proteins, with
Akt suggested to be a key regulator. Maximal activation
of Akt occurs through phosphorylation of Ser473 and it
appears that Akt may have a relatively short period of
activation after an acute bout of resistance exercise [36].
Research into the regulation of Akt signalling by exercise
has produced conflicting results. A series of studies have
demonstrated that contractile activity either positively or
negatively regulates Akt activity [15,37-39], while others
failed to find any change [40-42]. In the current study,
we found that resistance exercise and nutrient ingestion
failed to induce a significant change in the phosphoryla-
tion of Akt.
Stimuli of the Akt pathway includes hormones and mus-
cle contraction. Insulin [43] and IGF-I [44] bind to their
respective membrane-bound receptors and subsequently
activate phosphatidylinositol-3 kinase (PI-3K), an
upstream activator for Akt phosphorylation. Quantifica-
tion of circulating IGF-I levels has yielded inconsistent
results, with levels being reported to decline [45], increase
[46], or remain unchanged [47] after the onset of exercise.
Furthermore, circulating IGF-1 has been shown to have
no direct effect on muscle hypertrophy [48]. In the current
study, we observed no changes in serum IGF-1 following
the exercise bout or due to nutrient ingestion, thereby sug-
gesting hepatically-derived IGF-1 to have no appreciable
effect on Akt pathway activation.
Serum insulin was increased in both groups. It is evi-
dent as to why insulin increased in the CHO group as
10 g of carbohydrate were ingested. In addition, the WP
group also underwent a similar increase in insulin in the
absence of ingested carbohydrate, which is in agreement
with the insulin response previously demonstrated with
20 g of whey protein (10 g EAAs) [49]. The Akt/mTOR
Table 4 Phosphorylated levels of Akt/mTOR pathway intermediates for WP and CHO
Variable Time Point WP CHO p-value
IRS-1 Baseline 15.68 ± 9.6 19.52 ± 6.4 Supplement (S) = 0.88
15 min post-exercise 29.04 ± 6.6† 22.28 ± 11.2 Test (T) = 0.04†#
120 min post-exercise 25.40 ± 6.0 19.65 ± 9.2 S × T = 0.44
Akt Baseline 5.04 ± 1.9 6.88 ± 1.1 Supplement (S) = 0.21
15 min post-exercise 6.04 ± 2.6 5.61 ± 4.1 Test (T) = 0.35
120 min post-exercise 4.78 ± 1.4 4.58 ± 2.1 S × T = 0.82
mTOR Baseline 3.34 ± 0.34 3.62 ± 0.19 Supplement (S) = 0.93
15 min post-exercise 3.75 ± 0.62 3.66 ± 0.27 Test (T) = 0.002†
120 min post-exercise 3.33 ± 0.19 3.52 ± 0.28 S × T = 0.34
P70S6K Baseline 8.51 ± 3.2 10.41 ± 3.2 Supplement (S) = 0.96
15 min post-exercise 14.14 ± 6.6 11.18 ± 2.9 Test (T) = 0.04
120 min post-exercise 13.32 ± 6.1 11.24 ± 5.0 S × T = 0.74
4E-BP1 Baseline 4.30 ± 2.4 5.33 ± 1.7 Supplement (S) = 0.28
15 min post-exercise 2.66 ± 1.3† 2.28 ± 1.0 Test (T) = 0.001†
120 min post-exercise 4.07 ± 1.9# 4.90 ± 1.8 S × T = 0.64
Data are means ± standard deviations.
p70S6K, eIF4E-BP1, AKT and IRS-1 are expressed as U/ml/mg.
mTOR is expressed as absorbance units at 450 nm/mg.
† represents significant difference from baseline at 15 min post-exercise.
# represents significant difference from baseline at 120 min post-exercise.
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signalling pathway is activated by insulin. Insulin binds
with its receptor and leads to an increase in tyrosine
phosphorylation of IRS-1 and eventually mTOR activa-
tion. In the present study, insulin significantly increased
in both groups 30 min post-supplement ingestion and 15
min post-exercise, which was mirrored by significant
increases in IRS-1 activation at 15 min post-exercise.
Even though Akt phosphorylation was not significantly
increased, activation of IRS-1 likely contributed to the
observed increases in mTOR activation; however, this
activity was not preferentially contingent on 10 g of whey
protein ingestion.
mTOR is a 289 kDa serine/threonine kinase down-
stream of Akt and stimulates protein synthesis through
downstream activation of p70S6K and 4E-BP1, providing a
key point of convergence for both resistance exercise and
amino acids [14]. Amino acid ingestion has been shown to
significantly enhance mTOR signalling [25,50]. In the pre-
sent study, the acute bouts of resistance exercise signifi-
cantly increased mTOR and p70S6K activation at 15 min
post-exercise, while a marked decrease in 4E-BP1 activa-
tion was also observed at 15 min post-exercise. While we
observed mTOR activation to be enhanced by resistance
exercise, the Akt/mTOR pathway signalling intermediates
we assessed were unaffected by the provision of 10 g of
whey protein comprised of 5.25 g EAAs.
Previous work has suggested that a minimal amount of
20 g is needed to stimulate MPS [10]; however, others have
demonstrated positive effects utilizing a dosage as low as
6 g EAAs [51]. Increases in MPS following resistance exer-
cise have been observed when utilizing 10 g of whey pro-
tein; however, the protein supplement was co-ingested
with 21 g of carbohydrate [26]. However, it has recently
been shown that approximately 5 g (2.2 g EAAs) and 10 g
(4.2 g EAAs) of whey protein without carbohydrate signifi-
cantly increased MPS 37% and 56%, respectively, over base-
line. In this study, it was also shown that 20 g (8.6 g EAAs)
maximally stimulated MPS following resistance exercise
[27]. Although, our results are supported by previous data
which demonstrated that 20 g of albumin protein (8.6 g
EAAs) enhanced MPS after resistance exercise, yet had no
effects on activation of the mTOR pathway intermediates,
S6K1, rps6, and eIF2Bε post-exercise [27], the dosage used
in the current study (10 g whey protein, 5.25 g EAA) was
apparently insufficient to reach an amino acid dosage cap-
able of stimulating Akt/mTOR pathway activity.
A number of limitations exist in the current study.
Firstly, we only assessed the relative changes in the phos-
phorlated levels of various Akt/mTOR pathway intermedi-
ates. Thus, these can only be used as markers indicative of
MPS. We did not measure protein synthesis directly and
thus caution needs to be taken when interpreting changes
in phosphorylation status of signaling pathway intermedi-
ates to imply changes in human MPS, as this does not
always determine functional changes. Secondly, no control
was used and thus no direct comparison between isoener-
getic carbohydrate and whey protein and resistance exer-
cise could be made. However, previous research has
clearly indicated that resistance exercise robustly activates
Akt/mTOR signalling. Thirdly, only one dosage was used
(10 g) and thus any comparison between other dosages
cannot be made directly. Finally, our study focused on the
early post-exercise recovery response in signalling and,
therefore, we acknowledge the possibility that long-term
activation of Akt/mTOR signalling and its downstream
targets such as at 6, 24, or 48 hr post-exercise may be bet-
ter indicators of muscle MPS over the course of a resis-
tance training program.
In conclusion, the present study shows that ingestion of
10 g whey protein (5.25 g EAAs) prior to a single bout of
lower body resistance exercise had no significant effect on
activating systemic and cellular signaling intermediates of
the Akt/mTOR pathway, otherwise indicative of MPS, in
untrained men. Future research should examine the effects
of dose response and timing of protein ingestion and com-
pare the effects of various forms/fractions of proteins on
post-exercise cell signalling responses to resistance
exercise.
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